I believe the key to success long term is product sales, regardless of whether the products have FDA approval, or not. Safety is certainly a key, as a product shouldn't be on the market if it's not safe, but I don't think the company should be that concerned about FDA Approved efficacy trials as long as they can bring product to market without them.
Short term, I believe announcing a strategy for U.S. sales will dramatically move the stock.
I really believe it's the FDA that needs to change. Their are virtually millions of products on the market where no degree of FDA approval exists. Big Pharma will tell you it costs them billions for each approved drug. Many drugs fail to get FDA approval as they don't improve on existing drug results, but rarely do they go to the added expense of showing that added to other drugs the treatment is improved.
Perhaps what I'm suggesting is a less rigorous treatment of these products that on submission of adequate anecdotal information, the FDA acknowledges that benefits have been seen from the use of a given product. It doesn't say the product is better than all others, but it has benefits, and it should be up to Doctor's to use the product, in addition to others, to try to get the best results for the patient.
I believe that if companies had the option of having the FDA pay for testing, and the FDA could collect several times their costs back from royalties on approved drugs, not only would the cost of approved drugs come down dramatically, but it would become a far faster process. The big difference would be the FDA wouldn't be suspicious of cheating if they were the ones doing the trials.
I personally take only the supplements that my Doctor's go along with, and when I've questioned using others, the answer I received was, your blood tests show that they'll be of no, or little benefit, or let me order some test to see if they'd be of benefit. I.E. my Doctor knows what the supplement should be used for, and at this time doesn't see it as being needed. I respect such Doctor's. I do not respect those who indicate that no supplement is needed because they don't have FDA Approval.
It's up to OWCP as to how far they go with FDA, but if full approval costs hundreds of millions, the only drug I would consider it for is for treating multiple myeloma. I believe that efficacy with psoriasis, acne, eczema, etc can be judged by the patient as much as the Doctor's. Anecdotal evidence of the effectiveness of our cannabis based cream should be all that's needed to make it a blockbuster product over time.
I believe our share price ought to reach $3+ once sales have been initiated, and are seen to be expanding to multiple countries, or states. This equates to approaching a half billion dollar market cap. Within six months if sales growth is clearly happening, a one to three billion dollar market cap is very possible. I.E. up to around $20. Let's get those initial sales going and watch what happens.
Gary
Short term, I believe announcing a strategy for U.S. sales will dramatically move the stock.
I really believe it's the FDA that needs to change. Their are virtually millions of products on the market where no degree of FDA approval exists. Big Pharma will tell you it costs them billions for each approved drug. Many drugs fail to get FDA approval as they don't improve on existing drug results, but rarely do they go to the added expense of showing that added to other drugs the treatment is improved.
Perhaps what I'm suggesting is a less rigorous treatment of these products that on submission of adequate anecdotal information, the FDA acknowledges that benefits have been seen from the use of a given product. It doesn't say the product is better than all others, but it has benefits, and it should be up to Doctor's to use the product, in addition to others, to try to get the best results for the patient.
I believe that if companies had the option of having the FDA pay for testing, and the FDA could collect several times their costs back from royalties on approved drugs, not only would the cost of approved drugs come down dramatically, but it would become a far faster process. The big difference would be the FDA wouldn't be suspicious of cheating if they were the ones doing the trials.
I personally take only the supplements that my Doctor's go along with, and when I've questioned using others, the answer I received was, your blood tests show that they'll be of no, or little benefit, or let me order some test to see if they'd be of benefit. I.E. my Doctor knows what the supplement should be used for, and at this time doesn't see it as being needed. I respect such Doctor's. I do not respect those who indicate that no supplement is needed because they don't have FDA Approval.
It's up to OWCP as to how far they go with FDA, but if full approval costs hundreds of millions, the only drug I would consider it for is for treating multiple myeloma. I believe that efficacy with psoriasis, acne, eczema, etc can be judged by the patient as much as the Doctor's. Anecdotal evidence of the effectiveness of our cannabis based cream should be all that's needed to make it a blockbuster product over time.
I believe our share price ought to reach $3+ once sales have been initiated, and are seen to be expanding to multiple countries, or states. This equates to approaching a half billion dollar market cap. Within six months if sales growth is clearly happening, a one to three billion dollar market cap is very possible. I.E. up to around $20. Let's get those initial sales going and watch what happens.
Gary
3
